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Temporal ChIP-on-chip reveals Biniou
as a universal regulator of the visceral
muscle transcriptional network
Janus S. Jakobsen,1 Martina Braun,1 Jeanette Astorga,2 E. Hilary Gustafson,1 Thomas Sandmann,1
Michal Karzynski,1 Peter Carlsson,2 and Eileen E.M. Furlong1,3
1European Molecular Biology Laboratory, D-69117 Heidelberg, Germany; 2Department of Cell and Molecular Biology,
Goteborg University, SE-405 30 Goteborg, Sweden
Smooth muscle plays a prominent role in many fundamental processes and diseases, yet our understanding
of the transcriptional network regulating its development is very limited. The FoxF transcription factors are
essential for visceral smooth muscle development in diverse species, although their direct regulatory role
remains elusive. We present a transcriptional map of Biniou (a FoxF transcription factor) and Bagpipe
(an Nkx factor) activity, as a first step to deciphering the developmental program regulating Drosophila
visceral muscle development. A time course of chromatin immunoprecipitatation followed by microarray
analysis (ChIP-on-chip) experiments and expression profiling of mutant embryos reveal a dynamic map of in
vivo bound enhancers and direct target genes. While Biniou is broadly expressed, it regulates enhancers
driving temporally and spatially restricted expression. In vivo reporter assays indicate that the timing of
Biniou binding is a key trigger for the time span of enhancer activity. Although bagpipe and biniou mutants
phenocopy each other, their regulatory potential is quite different. This network architecture was not apparent
from genetic studies, and highlights Biniou as a universal regulator in all visceral muscle, regardless of its
developmental origin or subsequent function. The regulatory connection of a number of Biniou target genes is
conserved in mice, suggesting an ancient wiring of this developmental program.
[Keywords: Biniou; Bagpipe; visceral muscle; ChIP-on-chip; transcriptional network; temporal regulation]
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Genetic and molecular studies have made substantial
progress in identifying key regulators essential for the
specification of tissue primordia. Yet relatively little is
known about the regulatory networks governing their
subsequent differentiation into functional tissues. This
is particularly true for the smooth muscle. In contrast to
cardiac and skeletal muscle development, where the
regulatory connectivity of multiple transcription factor
(TF) families have been intensively studied (Pax3, MyoD,
Mef2, BMP, Nkx, GATA, to name a few) (Doevendans
and van Bilsen 1996; Black and Olson 1998; Baylies and
Michelson 2001; Lamey et al. 2004; Berkes and Tapscott
2005), the transcriptional network governing visceral
smooth muscle development remains largely uncharac-
terized.
Vertebrate visceral muscle (VM) consists of diverse
muscle types that develop from different embryonic ori-
gins, and perform various functions ranging from blood
vessel constriction and urogenital tract contraction, to
the peristaltic movement of the gut. As a consequence,
smooth muscle defects contribute to a host of human
diseases including hypertension, asthma, and diseases af-
fecting the gut connective tissue. In invertebrates, the
situation is somewhat simpler. Drosophila embryos
have four types of VM that all contribute to the gut mus-
culature (for review, see Lee et al. 2005). Despite their
different embryological origins, all VM in flies and hu-
mans display slow supercontractions, distinguishing
them from skeletal (somatic) and cardiac muscle (Gold-
stein and Burdette 1971; Bitar 2003).
It is perhaps not surprising that a tissue with such
fundamental function as moving food through the gut
has many developmental and structural homologies
across metazoans. What is more intriguing is the essen-
tial role of key regulators of VM development from flies
to vertebrates. Mutations in FoxF TFs cause defects in
gut muscle differentiation in both mice (Mahlapuu et al.
2001a; Wang et al. 2003; Ormestad et al. 2004, 2006) and
Xenopus (Tseng et al. 2004), similar to those observed in
flies (Zaffran et al. 2001). Likewise, BapX is required for
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the specification of subtypes of VM in mice (Lettice et al.
1999) and flies (Azpiazu and Frasch 1993). This high level
of functional conservation suggests that the underlying
transcriptional circuitry governing VM development
may also be conserved.
To date, most progress has been made in elucidating
the genetic program required for VM development in
Drosophila (Kusch and Reuter 1999; San Martin and Bate
2001; Lee et al. 2005). The trunk VM is specified through
the combined action of inductive signals from the over-
lying ectoderm (dpp, a BMP family member) and intrin-
sic factors in the underlying splanchnic mesoderm (the
TFs Tinman and sloppy-paired) (Frasch 1995; Riechmann
et al. 1997; Lee and Frasch 2000). At the molecular level,
the direct inputs from Dpp, Tinman and Sloppy-paired
are integrated in a cis-regulatory module (CRM) that con-
trols the expression of bagpipe, a BapX ortholog (Lee and
Frasch 2005). Bagpipe, an Nkx TF, together with Dpp,
regulates the expression of the FoxF TF, biniou (Zaffran
et al. 2001).
Both Bagpipe and Biniou are essential for the specifi-
cation of trunk VM. Embryos lacking either TF have a
complete absence of circular midgut muscle (Azpiazu
and Frasch 1993; Zaffran et al. 2001). Although the up-
stream regulators of both factors are well characterized,
their downstream effectors are largely unknown. How do
Bagpipe and Biniou regulate VM specification? Are these
TFs only required for this process? The broad temporal
and spatial expression of biniou suggests that it may be
required to regulate other aspects, potentially all aspects,
of the VM developmental program. However, there are
currently too few characterized target genes and CRMs
known to make accurate models about Biniou’s direct
regulatory role; only three direct target genes have been
identified to date. Biniou provides positive feedback
regulation to bagpipe during trunk VM specification
(Zaffran et al. 2001). The two other target genes, dpp
(Zaffran et al. 2001) and 3-tubulin (Zaffran and Frasch
2002), are required for midgut morphogenesis (Mathies
et al. 1994; Dettman et al. 1996). The lack of trunk VM
in biniou mutant embryos has precluded a detailed un-
derstanding of its function during later stages of VM de-
velopment.
To decipher the transcriptional program regulating
VM development within its in vivo context, we have
used two complementary global approaches to system-
atically identify VM CRMs and their associated target
genes during a developmental time course. The integra-
tion of expression profiling of biniou mutant embryos
with chromatin immunoprecipitation followed by mi-
croarray analysis (ChIP-on-chip) experiments produced a
temporal map of Biniou activity, revealing dynamic en-
hancer occupancy in vivo. Transgenic reporter assays
indicate that the timing of Biniou enhancer binding pre-
cisely matches the timing of enhancer activity. Integrat-
ing these data with in vivo binding of Bagpipe showed
that Bagpipe targets a restricted subset of CRMs during
the early stages of VM specification. These data provide
an initial global map of the regulatory circuitry driving
the progression of VM development in flies, and high-
lights that at least some of the transcriptional wiring is
conserved in mice.
Results
A developmental time course of gene expression
during VM development
To identify genes genetically downstream from biniou,
we compared the expression profiles of wild-type em-
bryos to tightly stage matched biniou mutant embryos
during a developmental time series. Biniou mutants lack
circular VM, which normally covers the midgut, and
have secondary defects in longitudinal VM (Zaffran et al.
2001). Pure populations of biniou homozygous mutant
embryos were isolated from their balancer siblings using
an automated embryo sorter and manually censored, as
described previously (Furlong et al. 2001a,b). Five con-
secutive 1-h time periods were examined, covering the
stages of VM specification, migration, and the initiation
of terminal differentiation (Fig. 1A). An additional time
period was analyzed at the end of embryogenesis (stage
16) to identify genes potentially involved in VM terminal
differentiation and function. A complementary genetic
background was also examined: embryos with ectopic
biniou expression throughout the mesoderm (Fig. 1A).
These experiments identified 1164 genes with signifi-
cant changes in gene expression at one or more develop-
mental time points or conditions, with ∼11 predicted
false positives (Supplementary Fig. 1; Supplementary
Table 1). Of these, 639 genes had reduced expression in
biniou loss-of-function mutants (Supplementary Fig. 1,
clusters 1 and 2). These include many genes specifically
associated with VM development (e.g., bap, Fas3, Con,
pnt, HLH54F, and hand), more generally expressed
muscle genes (sns, lmd, 3tub60D), as well as 415 genes
of unknown function (predicted CGs). In contrast, 525
genes had increased expression in biniou mutants,
which may represent a secondary systemic response of
the embryo to a block in VM development (Supplemen-
tary Fig. 1, clusters 3 and 4).
Systematic mapping of Biniou-bound enhancers
and direct target genes during embryogenesis
The expression profiling identified a large number of pre-
viously uncharacterized genes as genetically down-
stream from biniou. We next set out to determine which
genes are directly regulated by this TF and to identify the
associated enhancer regions. ChIP-on-chip was per-
formed against the endogenous Biniou protein during a
developmental time course. Four consecutive 2-h time
points were examined, covering the stages of visceral
mesoderm induction to the initiation of terminal muscle
differentiation (Fig. 1A, stages 10–15). To reduce the
number of false positives due to possible nonspecific
binding of the antiserum, two independent anti-Biniou
antisera were used for the immunoprecipitations. These
samples were hybridized to a tiling array consisting of
overlapping 3-kb fragments covering ∼50% of the Dro-
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sophila genome (Sandmann et al. 2006). Only regions
that were significantly enriched using both antibodies
were considered to be Biniou-bound enhancer regions.
Using these stringent criteria we identified 292
Biniou-bound regions at one or more developmental
time points with a false discovery rate of <1% (Supple-
mentary Table 2). Due to the overlapping nature of the
microarray, this represents 218 unique genomic regions.
This set includes all known Biniou-bound enhancers,
namely bagpipe (Lee and Frasch 2005), -Tubulin at 60D
(Zaffran and Frasch 2002), and dpp (Zaffran et al. 2001)
enhancer regions (Supplementary Fig. 2).
As metazoan enhancers can work over long distances,
and do not necessarily regulate the closest gene, connect-
ing enhancer data to the correct target gene is very chal-
lenging. To link Biniou-bound regions to their puta-
tive target genes we used a systematic approach (Supple-
mental Material). In brief, a cumulative score was given
to all genes in the vicinity of a Biniou-bound region
based on (1) proximity; (2) requirement of biniou func-
tion for normal expression, determined by expression
profiling of biniou loss-of-function mutant embryos de-
scribed above; (3) the ability of ectopic Biniou to increase
the gene’s expression; and (4) spatial expression overlap-
Figure 1. Biniou-bound enhancers drive expression in diverse spatial domains. (A) Schematic diagram showing the experimental
design. The green arrow indicates Biniou’s continuous expression from stage 10 (∼6 h after egg laying) to the end of embryogenesis.
ChIP-on-chip experiments were conducted at four consecutive 2-h time points (dark-blue bars). This was complemented by expression
profiling of biniou loss-of-function and gain-of-function mutant embryos at 1-h time points, indicated by the light-blue bars. (B) A
schematic diagram of VM development showing the four different primordia that give rise to foregut (yellow), hindgut (purple), trunk
(red), and longitudinal (green) VM during stages 11, 13, and 16 of embryogenesis (modified from Lee et al. 2006). (C) Immunostaining
of Biniou in wild-type embryos at developmental stages 11, 13, and 16. The foregut and hindgut VM are indicated by black arrows.
(D–G) Schematic overviews of four Biniou-bound regions used in transgenic reporter strains: The gene is depicted at the bottom of the
panel, with exons in black and introns in gray. Genomic fragments on the tiling arrays are indicated as stacks of four horizontal gray
bars in their corresponding genomic position. Each single bar represents the results from one ChIP-on-chip time period, with the
earliest (6–8 h) positioned at the top of the stack and the latest (12–14 h) at the bottom of the stack (blue arrow in D represents the
direction of time). The red bars indicate Biniou binding, while light-red bars represent binding just below our significance cutoff. Black
double-headed arrows mark the boundaries of the cloned regions. All enhancers are labeled by the target gene name, followed by VME
(VM enhancer). The green double-headed arrows indicate the known enhancers of bagpipe. (D–G) In situ hybridization of GFP
transcripts in transgenic enhancer-GFP embryos for the regions indicated in D–G. The four enhancer lines drive specific expression in
different subtypes of VM: longitudinal muscle (CG2330-VME) (D), trunk VM (lmd-VME) (E), and foregut and hindgut VM (bap-FH-
VME) (F). (G) Fluorescent in situ hybridization showing dac-VME expression in the trunk, foregut, and hindgut VM (white arrows).
In B–D, embryos are oriented with the anterior to the left and the dorsal at the top. All views are lateral, except E and G stage 16,
which are dorsal.
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ping with Biniou (from BDGP in situ data and the litera-
ture). This method proved very effective in linking Mef2-
bound regions to their target genes (Sandmann et al.
2006). Using these criteria, 224 of the 292 bound regions
were assigned to 146 direct target genes (Supplementary
Table 3). This systematic approach correctly assigned
the three known Biniou enhancers to their appropriate
target gene, and also assigned a number of genes known
to be genetically downstream from biniou (e.g., vimar,
FasIII, bnl). All Biniou-bound regions and surrounding
genes can be visualized at http://furlonglab.embl.de/data/
browse_chip_mod.
Biniou-bound regions drive expression in spatially
restricted subdomains of the VM
The regulatory potential of four Biniou-bound regions
was tested in vivo by examining their ability to drive
GFP expression in transgenic animals. Conservation in
other Drosophila species and the location of predicted
Biniou motifs (Supplemental Material) were used as
guides to select smaller regions within the Biniou-bound
genomic fragments. All four regions were sufficient to
function as enhancers in vivo, regulating expression in
domains overlapping that of Biniou.
Biniou is expressed in all four subtypes of VM: the
trunk VM and longitudinal VM surrounding the midgut,
the foregut VM, and the hindgut VM (Fig. 1B). Although
Biniou has a broad spatial expression (Fig. 1C), it regu-
lates enhancers that drive expression in spatially
restricted subtypes and subdomains of the VM. The 930-
base-pair (bp) enhancer region for CG2330 drives expres-
sion in the longitudinal VM, where it initiates expres-
sion soon after the onset of Biniou expression and con-
tinues to be expressed until the end of embryogenesis
(Fig. 1D,D). In contrast, the enhancer region for lmd
drives expression in the trunk VM during early stages of
development and is not expressed in VM later in devel-
opment (Fig. 1E,E). In the bagpipe locus, the previously
identified bap3.5 enhancer (Lee and Frasch 2005) drives
expression in both the foregut and hindgut visceral me-
soderm (Fig. 1F, double-headed green arrow 3). Here, we
show that this enhancer is bound by Biniou in vivo and
report the boundaries of a smaller region (reduced from
the previously reported 3.5 kb to 2.1 kb) that is sufficient
to drive expression in these two VM populations from
stage 10 until the end of embryogenesis (Fig. 1F).
Biniou binding within the dachshund gene locus (Fig.
1G) was detected just below our stringent cutoff for en-
richment (q-value of 0.046 instead of <0.01). Members of
the dachs, eyes absent, and six family of transcriptional
regulators are essential for skeletal muscle development
in vertebrates. As dacs has no reported role in Dro-
sophila muscle development it was of interest to exam-
ine the expression of this Biniou-bound region. This en-
hancer is sufficient to drive expression in the foregut and
hindgut VM, in a group of cells in the central part of the
trunk VM, as well as in the salivary glands (Fig. 1G,
arrows). The observed expression is broader than that of
the endogenous dac gene, which is limited to the hind-
gut domain (Kumar and Moses 2001). This may reflect
the absence of some negative regulatory inputs from the
cloned enhancer region.
In summary, these data and those presented below
demonstrate that our ChIP-on-chip results provide an
accurate and sensitive global map of Biniou-bound en-
hancers, and that these regions drive expression in all
four subtypes of VM.
Biniou binds to three temporal groups of enhancers
The broad temporal expression of Biniou (stages 10–17)
suggests a regulatory role during all stages of VM devel-
opment. The direct regulation of 3-tub60D (Zaffran and
Frasch 2002), a gene expressed continuously in the de-
veloping gut muscle, supports this model. However,
Biniou also directly regulates bagpipe expression via the
characterized bap3 enhancer (Lee and Frasch 2005). In
contrast to 3-tub60D, bagpipe is expressed in a narrow
developmental window, indicating that Biniou can also
regulate more transient gene expression. We used our
ChIP-on-chip time course to obtain a global view of the
temporal enhancer occupancy of Biniou during develop-
mental progression.
K-medians clustering was used to group the 292 bound
regions based on their levels of enrichment through de-
velopmental time. This analysis revealed three robust
groups of temporally occupied enhancers (Fig. 2A;
Supplementary Table 2). Almost half of the CRMs (47%)
are bound by Biniou at all four time points assayed, span-
ning stages 10–15 (Fig. 2A, continuously bound). This
continuous enhancer binding mirrors the TF’s continu-
ous expression and suggests a requirement for Biniou to
regulate the associated target genes during all stages of
VM development.
Surprisingly, Biniou binds to two additional groups of
enhancers in temporally distinct patterns. Twenty-two
percent of enhancer regions are only bound by Biniou
early in development (Fig. 2A, early-bound, stages 10–
11), and are not bound at later developmental stages (14–
15). In contrast, 31% of Biniou-bound enhancers are spe-
cifically bound at late stages in development, but not
during the early stages of VM specification (Fig. 2A, late-
bound). As Biniou protein is expressed continuously in
these cells, the early-bound and late-bound enhancers
were unexpected and demonstrate that Biniou activity is
regulated at the level of its enhancer binding.
Biniou enhancer binding determines the timing
of enhancer activity
The dynamic enhancer binding suggests that the timing
of Biniou occupancy is important for the timing of en-
hancer activity. To assess this in vivo, a number of re-
gions from each temporal cluster (Fig. 2A) were linked to
a GFP reporter. The timing of enhancer activity was as-
sayed in vivo by in situ hybridization in transgenic em-
bryos, to avoid time delays due to GFP protein folding
and protein perdurance. All regions examined drive ex-
pression in a subset of Biniou-expressing cells and re-
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capitulate all or part of the target genes’ expression (see
Supplementary Fig. 3 for a detailed description). Here we
focus on their temporal activity.
The initiation of enhancer activity closely matches
the first time point of Biniou binding for >90% of en-
hancers examined (10 of 11 CRMs) (Figs. 1, 2). The early-
Figure 2. Dynamic enhancer binding. Biniou acts as a trigger for CRM activity. (A) Biniou binds to CRMs in three temporal groups:
K-median clustering of the enrichment levels of Biniou binding in each consecutive time period uncovered three groups of enhancers
bound either early, continuously, or late in development. Each row represents a Biniou-bound enhancer region, while each column
represents one developmental time period, with stages 10–11 (6–8 h) to the left and stage 15 (12–14 h) to the right. The level of Biniou
enrichment is displayed as a heat map, in which black reflects no enrichment and dark yellow represents high enrichment, quantified
in the scale below the clustergram (log2). (B–I) The time span of Biniou binding correlates with enhancer activity: in situ hybridization
of GFP transcripts in transgenic enhancer lines using enhancer regions from each temporal class in A. (B) The enhancer in the ttk locus
is transiently expressed in the VM (stages 10–11) and somatic muscle (stages 11–13). (C) fd64a early enhancer drives expression in the
hindgut VM from stages 11–13. (D–F) Three continuously bound enhancers drive expression from stages 11–16 in the longitudinal VM
(HLH54F-VME; D) or trunk VM (otk-VME; E). (F) mib-2 enhancer drives expression in the VM and somatic muscle from stages 11–13.
Only somatic muscle expression is maintained at stage 16. (G) The fd64a late enhancer drives expression in a subset of the anterior
and posterior region of the trunk VM from stages 13–15 (arrow). There is no early expression prior to the time point of Biniou binding.
(H) The ken enhancer is expressed in the salivary gland and neuronal tissue at stage 13, and initiates expression in the foregut VM at
stage 15 (arrow), matching the timing of Biniou binding. (I) Fluorescent in situ hybridization of biniou (green) and GFP (red) of the
ken-VME showing coexpression in the foregut VM at stage 15 (white arrow). All embryos at stages 11 and 13 are lateral views. Stage
16 embryos in B, C, E, and G are lateral views; F is ventral; and D, H, and I are dorsal views.
Jakobsen et al.
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bound enhancers drive expression at stages 10–11, re-
flecting the binding of Biniou at these stages of develop-
ment: ttk enhancer (Fig. 2B), fd64a-e enhancer (Fig. 2C),
lmd enhancer (Fig. 1E), bap3 enhancer (Supplementary
Table 2; Lee and Frasch 2005). Similarly, all four con-
tinuous-bound enhancers initiate expression at the first
time period when Biniou binds (stages 10–11): HLH54F
enhancer (Fig. 2D), otk enhancer (Fig. 2E), mib2 enhancer
(Fig. 2F), bap-FH enhancer (Fig. 1F). The two late-bound
enhancers, on the other hand, do not initiate expression
at stages 10 or 11 of development, matching the lack of
Biniou binding during these stages (Fig. 2G,H, cf. A). In-
stead, the expression of the fd64a late enhancer initiates
at stage 13 (Fig. 2G, arrow), while the ken enhancer ini-
tiates VM expression at stage 14 (Fig. 2H,I, arrow). This
shift in the initiation of activity mirrors Biniou binding
to these enhancers at stages 12–13 and 13–14, respec-
tively (Fig. 2A). The only exception is the CG2330 en-
hancer, which initiates expression at stage 11, while
Biniou enhancer binding was first detected at stage 13–
14 (Fig. 1D,D). As the expression of endogenous CG2330
does not initiate until stage 13 (Supplementary Fig. 4),
the apparent discrepancy in enhancer activity may sim-
ply reflect the exclusion of some regulatory motifs
within the limits of the cloned region.
Remarkably, the duration of enhancer activity is also
tightly correlated with the time span of Biniou binding
in 10 out of 11 CRMs examined (∼90%). This is particu-
larly striking in the early-bound enhancers: When Biniou
ceases to bind to these CRMs, their ability to regulate
expression is lost: lmd (Fig. 1E), ttk (Fig. 2B), fd64a early
(Fig. 2C), and bap3 (Supplementary Table 2). The con-
verse is also true. Continuous Biniou binding correlates
with continuous enhancer activity: bap-FH enhancer
(Fig. 1F), HLH54F enhancer (Fig. 2D), and otk enhancer
(Fig. 2E). The exception is the mib2 enhancer (Fig. 2F). In
the context of this module Biniou binding it is not suf-
ficient to maintain enhancer activity in the VM at late
developmental time points.
Taken together, these data indicate that the timing of
Biniou enhancer binding is predictive for temporal en-
hancer activity in the large majority of cases.
Differential enrichment of TF motifs distinguish
the three classes of Biniou–CRMs
All 11 Biniou enhancers examined in vivo regulate ex-
pression in more restricted patterns than Biniou itself.
As Biniou has broad temporal and spatial expression, ad-
ditional regulatory inputs must refine Biniou’s activity
in a combinatorial manner. To identify other factors that
may impinge on these enhancers we searched for over-
represented motifs within the Biniou-bound CRMs. This
analysis identified significant enrichment of a number of
TF motifs (Supplementary Fig. 5). Of particular interest
is the differential enrichment of motifs for Biniou, Mef2,
and Nkx family proteins, Bap and Tin, between the three
temporal classes of enhancers (Fig. 3).
Interestingly, the Bap motif is specifically enriched in
the early-bound enhancers, and not in the continuous- or
late-bound group (Fig. 3). Tin motifs are also enriched in
the early-bound group (Fig. 3). This is in agreement with
the transient expression of both TFs in the trunk VM
during early stages development (stages 10–11) (Azpiazu
and Frasch 1993; Bodmer 1993), and suggests that one or
both of these TFs could impart some of the specificity for
Biniou transient binding to these enhancers.
The Mef2 motif is highly enriched in both early- and
continuous-bound enhancers, but not in late VM en-
hancers (Fig. 3). This was surprising as Mef2 regulates
muscle differentiation genes and was therefore expected
to coregulate late-bound enhancers. To substantiate this
further, we compared in vivo bound Mef2 enhancers,
identified in our previous study (Sandmann et al. 2006),
with the Biniou-bound enhancer regions at the same
stages of development. In agreement with the motif en-
richment, there is substantial combinatorial binding of
Biniou and Mef2 on the early-bound and continuous-
bound enhancers: 65.1% and 50.4%, respectively (Sup-
plementary Fig. 6). In contrast, only 20.1% of the late
Biniou-bound enhancers are cobound by Mef2. The same
trend holds true in the other direction: There is no sig-
nificant Biniou binding to many enhancers regulated by
Mef2 at late developmental stages (e.g., the Mef2-bound
enhancers for the contractile proteins Mhc, Mlc1, and
Mlc2) (Sandmann et al. 2006). This indicates that the VM
may have two largely independent differentiation pro-
grams, one governed by Mef2 regulating more general
muscle contractile proteins, and a second more VM-spe-
cific program driven by Biniou.
Figure 3. Differential enrichment of transcription motifs be-
tween the early-bound, continuously bound, and late-bound en-
hancers. The three temporal groups of enhancers (early-bound,
continuously bound, and late-bound) are enriched in different
TF motifs. The histogram shows the level of motif enrichment
in the ChIP-bound enhancers compared with background
(Y-axis) for Bin, Bap, Tin, and Mef2 motifs. Motif enrichment is
defined as the number of motifs per kilobase within the enhanc-
ers divided by the number of motifs per kilobase in random
“background” DNA. Bap motifs are significantly overrepre-
sented in the Biniou early-bound enhancers but not in the con-
tinuously or late-bound regions. Mef2 motifs are highly en-
riched in both the early-bound and continuously bound enhanc-
ers. While Tin motifs are strongly enriched in the early group,
the continuous group has only a slight overrepresentation of
this motif. The Biniou motif is enriched in all three groups, with
particularly high enrichment in the continuously bound and
late-bound enhancers. (●) P < 0.05; (●●) P < 0.01; (●●●) P < 0.001.
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Biniou consensus motifs are overrepresented in all
three classes of temporal enhancers, providing global
confirmation of the specificity of the ChIP-bound re-
gions. Biniou motifs are particularly highly enriched in
the continuous-bound and late-bound enhancers (Fig. 3).
This highlights a prominent role for Biniou in regulating
enhancer activity at late stages of VM development. The
inability of Biniou to bind to the late enhancers at early
stages of development implies a mechanism that either
blocks Biniou binding to these CRMs early in develop-
ment or enhances Biniou’s binding later in development.
This could be mediated by many different mechanisms.
Binding of the C.elegans FoxA TF, PHA-4, to early versus
late pharyngeal muscle enhancers is primarily deter-
mined by the presence of high or low affinity binding
sites, respectively (Gaudet and Mango 2002). We de-
tected no apparent differences in the Biniou motif be-
tween the early- and late-bound VM enhancers, and
therefore favor a combinatorial model with as-yet-un-
identified cofactors. This is strongly supported by the
restricted expression of all Biniou-bound CRMs exam-
ined, necessitating extensive combinatorial regulation to
limit their activity.
Combinatorial binding to early VM enhancers
by Bagpipe and Biniou
The specific enrichment of Bagpipe motifs in Biniou
early-bound CRMs, in addition to the similarity of
bagpipe and biniou mutant phenotypes, implies a poten-
tial for combinatorial regulation by these two TFs during
the stages of VM specification.
As Biniou is downstream from Bagpipe, it has been
very difficult to differentiate between a direct regulatory
role by Bagpipe versus an indirect requirement via
Biniou using genetic studies. To investigate the molecu-
lar function of bagpipe and its potential occupancy on
Biniou-bound CRMs, we performed ChIP-on-chip experi-
ments using anti-Bagpipe antibodies. As described for
Biniou, these experiments were performed with four bio-
logical repeats using two independent anti-Bagpipe anti-
sera. The ChIPs were performed at stages 10–11 (6–8 h),
covering the time span when bagpipe is transiently ex-
pressed in the trunk VM. This experiment identified 80
Bagpipe-bound genomic regions, using the same criteria
as the Biniou experiments (Supplementary Table 4).
A number of genomic regions are exclusively bound by
Bagpipe, with no detectable Biniou binding at stages
10–11 of development (Fig. 4A,D, Group 3). For example,
the Bagpipe-bound region within the intron of CG8503:
This enhancer is sufficient to drive transient expression
in the trunk VM at stages 10–11 (Fig. 4B, arrow), reflect-
ing the transient expression of bagpipe in this tissue.
Other Bagpipe-bound enhancer regions contain low lev-
els of Biniou binding (below our significance cutoff). The
slp1 enhancer is within this class. This region drives
expression in the foregut VM (Fig. 4C, arrow), recapitu-
lating the endogenous gene’s expression. Together these
enhancers demonstrate that Bagpipe provides a direct
regulatory role within the VM developmental program,
independently of Biniou.
In contrast, 51% of Bagpipe enhancers are cobound by
Biniou at the same stage of development (Fig. 4A). This
Figure 4. Combinatorial binding of Bag-
pipe and Biniou during VM specification.
(A) A Venn diagram showing the overlap of
Bagpipe- and Biniou-bound enhancers at
stages 10–11 (6- to 8-h time period). Fifty-
one percent of Bagpipe-bound CRMs are co-
bound by Biniou. Biniou regulates twice
as many CRMs as Bagpipe during these
stages of VM development. The majority of
Bagpipe’s regulation is mediated via combi-
natorial binding to a subset of Biniou-bound
CRMs. (B,C) In situ hybridization of re-
porter transcripts for two Bagpipe-bound en-
hancers. (B) The CG8503 CRM drives tran-
sient expression in the trunk VM at stage 11
(arrow), in addition to somatic muscle ex-
pression. (C) The slp1 enhancer drives spe-
cific expression in the foregut VM from
stage 13 (arrow). (D) The Bagpipe-bound
CRMs fall into three clusters, distinguished
by their temporal occupancy of Biniou.
Group 1 enhancers are cobound by Bagpipe
and Biniou at stages 10–11 and remain
bound by Biniou throughout development,
while Group 2 enhancers are transiently
bound by Biniou at early stages. Group 3
enhancers are largely not bound by Biniou,
and represent the only Bagpipe-specific
CRMs identified. The levels of enrichment
are indicated by the color scale (log2).
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extensive combinatorial binding provides the first evi-
dence of global coregulation by these TFs during early
stages of VM specification. These cobound enhancers
(Fig. 4A) suggests that transient Biniou occupancy on
early group enhancers (Fig. 2A), may in part be due to
cobinding with Bagpipe, which is transiently expressed
at these stages. To investigate this we examined the tem-
poral profile of Biniou binding to the 80 Bagpipe-bound
CRMs using K-means clustering. Two distinct classes of
Biniou–Bagpipe-cobound CRMs were apparent (Fig. 4D):
Group 1 enhancers are cobound at stages 10–11 and re-
main continuously bound by Biniou at later develop-
mental time points. This indicates that Biniou does not
require the presence of Bagpipe to bind to the trunk VM
enhancers among this class. In contrast, Group 2 enhanc-
ers are cobound by Biniou and Bagpipe at stages 10–11 of
development, but are largely not bound by Biniou later in
development (Fig. 4D). In the context of these early en-
hancers, Bagpipe binding may be the temporal cue dic-
tating transient Biniou binding. Many of these CRMs are
likely to be cooperatively regulated by both TFs.
CRM binding reflects a regulatory requirement
for target gene expression
The extensive enhancer occupancy by Biniou suggests
that this TF is required to regulate a comprehensive tran-
scriptional program within the VM, both independently
and in combination with Bagpipe. This is strongly sup-
ported by our global analysis of gene expression in biniou
mutant embryos: A large number of genes have reduced
expression during the first three time points examined
(stages at which VM cells are still present in biniou mu-
tant embryos), demonstrating that biniou is genetically
required for their expression (Supplementary Fig. 1, clus-
ter 1). To assess this further we performed a detailed
analysis of the requirement of biniou for a number of
target genes’ expression in vivo and for enhancer activa-
tion in vitro.
In situ hybridization was performed on six Biniou di-
rect target genes in both biniou loss of function mutant
embryos and in transheterozygous deficiencies remov-
ing the bagpipe locus. mib2, CG17181, lmd, and salm
are direct targets of both Biniou and Bagpipe via shared
CRMs, while the otk and ken CRMs are only bound by
Biniou. Due to the complete absence of trunk gut muscle
in both mutants at late stages of development, the ex-
pression of all target genes in the trunk VM was exam-
ined at stage 11, when these cells are still present
(Azpiazu and Frasch 1993; Zaffran et al. 2001).
Five of the examined direct target genes are specifi-
cally expressed in the primordia of the trunk VM
(Fig. 5A–E, white arrowhead), three of which have addi-
tional expression within the hindgut and/or longitudinal
VM domain (Fig. 5A–C, asterisk). The expression of all
genes is severely diminished in the trunk VM in biniou
or bagpipe mutant embryos, compared with wild-type
(Fig. 5A–E,A–E). In contrast, the levels of expression
in the ectoderm (salm), nervous tissue (otk), and somatic
muscle (mib2, CG17181), tissues where biniou and
bagpipe are not expressed, remain unchanged (Fig. 5,
white arrows). The mutual genetic interdependency of
Biniou and Bagpipe in the trunk VM makes it difficult to
definitively show a direct requirement for one of the TFs
in this tissue in vivo. However, Biniou and Bagpipe are
not dependent on each other for their expression in the
foregut and hindgut VM (Zaffran et al. 2001), providing a
useful system to confirm direct regulation by either TF.
Three genes with enhancers bound by both TFs, mib2,
CG17181, and lmd, are expressed in the hindgut VM
(Fig. 5A–C, asterisk). All three genes have diminished
hindgut VM expression in biniou and bagpipe mutant
embryos (Fig. 5 A–C,A–C, asterisk), indicating a direct
requirement for Biniou and Bagpipe to regulate their ex-
pression. This is particularly striking for mib2 and lmd
(Fig. 5, asterisk, cf A,C and A,C). The sixth gene exam-
ined, ken, is expressed in the foregut VM from stage 14,
as well as in the overlying ectoderm (Fig. 5F, asterisk and
arrow, respectively). The foregut enhancer of ken (Fig.
2H,I) is specifically bound by Biniou and not by Bagpipe.
The expression of this gene is severely reduced in biniou
mutant embryos and is unaffected in bagpipe mutants
(Fig. 5F–F), demonstrating direct regulation by Biniou,
independent of bagpipe activity.
To further examine the ability of Biniou to regulate
enhancer activity either independently or combinatori-
ally with Bagpipe we used an in vitro transient lucifer-
ase-reporter assay. Cotransfection of increasing amounts
of Biniou, Bagpipe, or a combination of both TFs was
used to asses their ability to regulate enhancer activity in
Drosophila Kc cells, a cell line of embryonic origin. All
assays were performed in triplicate with six independent
repeats to allow statistically analysis of enhancer activity.
Two enhancers that are cobound by Biniou and Bag-
pipe, the mib2 and CG17181 enhancers, were activated
by Biniou transfection up to approximately twofold (Fig.
5G). As predicted from the in vivo binding data, co-
expression of both Biniou and Bagpipe caused a signifi-
cant synergistic activation of enhancer activity. These
results, in combination with the reduced expression of
mib2 and CG17181 in biniou and bagpipe mutant em-
bryos (Fig. 5A,B), indicate cooperative regulation of these
enhancers in vivo. In contrast, the otk enhancer, which
is only bound by Biniou in vivo, was strongly activated
by this TF in vitro (up to 6.1-fold), and was not synergis-
tically activated by the addition of Bagpipe (Fig. 5G).
These results indicate that the trunk VM expression of
otk is largely regulated by Biniou, with little or no con-
tribution from Bagpipe. The specificity of Biniou activa-
tion of these three enhancers is highlighted by Biniou’s
inability to regulate an enhancer that it does not bind to,
the Bagpipe-bound CG8503 enhancer (Fig. 5G). This en-
hancer is highly activated by Mef2, demonstrating that
the enhancer construct is functional (Fig. 5G).
Interestingly, Bagpipe expression alone was not suffi-
cient to activate any enhancers tested in this in vitro
assay, suggesting that Bagpipe driven regulation gener-
ally requires recruitment of additional coregulators not
present in Kc cells. These results reveal an inherent dif-
ference between Biniou and Bagpipe as transcriptional
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activators: While Biniou is a potent activator with or
without Bagpipe, Bagpipe has little activation potential
by itself.
In summary, the in vivo binding of Biniou to enhanc-
ers independently or in combination with Bagpipe, its
ability to activity enhancers alone and synergistically
with Bagpipe, in addition to the in vivo requirement of
biniou for many target genes’ expression, demonstrate
Biniou’s prominent regulatory role within the transcrip-
tional program driving VM myogenesis. Previous studies
found no obvious hindgut or foregut defects in biniou
and bagpipe mutant embryos (Azpiazu and Frasch 1993;
Zaffran et al. 2001). However, our data show that a num-
ber of Biniou-bound CRMs drive expression in the hind-
gut or foregut VM (fd64a-early [Fig. 2C], ken [Fig. 2H,I],
bap-FH [Fig. 1F]), and that many direct target genes have
reduced expression in these tissues in biniou mutant
embryos (Fig. 5). These results clearly demonstrate that
Biniou directly contributes to the transcriptional net-
work within the foregut and hindgut VM, and further ex-
tends the regulatory role of this TF to all subtypes of VM.
Conservation in the FoxF regulatory circuitry
from flies to mice
The high conservation in the FoxF DNA-binding do-
main (64% amino acid identity between Biniou and
Figure 5. Biniou and Bagpipe activity are
essential for target gene expression. In situ
hybridization of six Biniou direct target
genes in wild-type embryos, biniou mutant
embryos (binR22), and bagpipe mutant em-
bryos [transheterozygotes of Df(3R)eF1 and
Df(3R)eD7Re28-58]. In all panels, trunk VM
is indicated by the white arrowhead and
hindgut or foregut VM are indicated by the
asterisk. (A,B) mib-2 and CG17181 are ex-
pressed in the trunk VM, hindgut VM, and
somatic muscle in wild-type embryos. The
VM expression is severely reduced in biniou
(A,B) or bagpipe (A,B) mutant embryos,
while the somatic muscle expression re-
mains unaffected (white arrows). (C) lmd
expression in the trunk VM and hindgut
VM is dramatically reduced in biniou (C)
and bagpipe (C) mutants. (D,E) salm and
otk are expressed in the trunk VM, as well
as the ectoderm and nervous system, re-
spectively. Only the VM expression is de-
pendent on Biniou (D,E) or Bagpipe (D,E )
activity, while the expression in the ecto-
derm and nervous system is similar to wild
type (white arrows). (F) ken is expressed in
the foregut VM (asterisk) and ectoderm
(white arrow) in wild-type embryos. The
VM expression is severely reduced in biniou
mutant embryos (F) but not in bagpipe mu-
tants (F ), consistent with the lack of Bag-
pipe binding to the ken enhancer. All pic-
tures are lateral views of stage 11 embryos,
with the exception of D–D, which are dor-
sal views, and F–F , which are lateral views
of stage 14. (G) Luciferase assays in Dro-
sophila Kc cells show both independent and
synergistic regulation of enhancers. For
each assay, 1 ng, 10 ng, or 100 ng of Biniou,
Bagpipe, or a combination of both transcrip-
tions was cotransfected with the enhancer
indicated. The two cobound enhancers,
mib2 and CG17181, are activated by Biniou
transfection and are synergistically acti-
vated by Biniou and Bagpipe cotransfection.
The Biniou-only enhancer, otk, is signifi-
cantly regulated by Biniou, with no synergistic activation by Bagpipe. In contrast, Biniou cannot activate the Bagpipe-only enhancer,
CG8503, which is highly activated by Mef2. Although the Bagpipe cDNA is clearly functional, demonstrated by the synergistic
activation of the mib2 and CG17181, Bagpipe alone was not sufficient to activate any enhancer regions tested. (●●) P < 0.01 by
Student’s t-test (n = 6).
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FoxF) (Zaffran et al. 2001) and the similarity in their gut
muscle phenotype suggests that these TFs may regu-
late an evolutionarily conserved set of direct target
genes.
To test the regulatory conservation between Biniou
and its target genes in vertebrates we examined the ex-
pression of three genes, for which we could identify a
clear mouse ortholog: otk (Ptk7 in mouse), salm (Sall4),
and HLH54F (Tcf21). In situ hybridization was per-
formed using probes directed against the mouse tran-
scripts in Foxf1 and Foxf2 mutant embryos (Fig. 6). As
Foxf1 and Foxf2 are partially functionally redundant
within the splanchnic mesoderm (Ormestad et al. 2004,
2006), target gene expression is expected to be only mod-
erately reduced in either single mutant. Double null mu-
tants cannot be generated as compound heterozygotes
die at birth (Ormestad et al. 2006). Foxf1−/− mutant em-
bryos die between embryonic day 9.5 (E9.5) and E10.5
(Mahlapuu et al. 2001b), while Foxf2−/− mutants develop
to term (Wang et al. 2003). We therefore examined the
expression of the orthologs of Biniou target genes at E8.5
in Foxf1−/− and at E12.5–E13.5 in Foxf2−/− embryos.
Murine FoxF genes are initially expressed in nascent
mesoderm of the primitive streak and are maintained in
lateral and extraembryonic mesoderm. Later their ex-
pression is confined to the splanchnic mesoderm and its
derivatives, such as the mesenchyme of gut (Mahlapuu
et al. 2001b; Ormestad et al. 2004). This broad expression
is reflected in the expression of their target genes. In
Drosophila, otk and salm are expressed in the primordia
of the trunk VM just after specification (Fig. 5E,D). In
mice, their orthologs, Ptk7 and Sall4, are expressed in
newly formed mesoderm within the primitive streak
area at the posterior end of the embryo (Fig. 6A,B; Kohl-
hase et al. 2002; Jung et al. 2004). Importantly, both
genes have consistently lower levels of expression in
Foxf1 homozygous mutant embryos compared with
wild-type littermates at E8.5, in all mutant embryos ex-
amined (Fig. 6A,B).
The HLH54F TF is specifically expressed in the Dro-
sophila longitudinal VM (Georgias et al. 1997). The
mouse ortholog, Tcf21 (also known as capsulin, epi-
cardin, or Pod1) initiates expression in the heart at E8.5
(Lu et al. 1998). This expression remains unaltered in the
FoxF2 knockout, consistent with the absence of FoxF
expression in this tissue. At later stages, Tcf21 is ex-
pressed in the smooth muscle layer of the gastrointesti-
nal and urogenital tracts (Fig. 6C). The expression in the
gut mesenchyme is significantly reduced in Foxf2 mu-
tant embryos (Fig. 6C).
Despite the expansion in FoxF TFs, our data indicate
that at least some of their regulatory connections are
conserved from flies to mice (Fig. 6D).
Discussion
To systematically dissect the transcriptional program
driving VM development in vivo, we used two comple-
mentary genomic approaches: a time course of ChIP-on-
chip experiments and expression profiling of mutant em-
bryos performed during consecutive stages of embryo-
genesis. This global view revealed the following insights
into the underlying cis-regulatory network:
Figure 6. Conservation in the Biniou-FoxF regulatory circuitry
from flies to mice. In situ hybridization in mouse embryos of
the orthologous genes of three Drosophila Biniou direct targets.
(A,A) Lateral views of a wild-type embryo and a Foxf1 litter-
mate at E8.5. The yolk sac was removed, while the allantois is
intact. Ptk7 (otk ortholog) expression in the primitive streak
region (A, arrow) is markedly reduced in Foxf1 mutant embryos
(A). (B,B) Sall4 (salm ortholog) is expressed in the primitive
streak region (B, arrow). (B) FoxF1 mutant embryos have con-
sistently lower primitive streak expression compared with wild-
type littermates (arrow). The insets in B and B show the dorsal
aspect of the primitive streak area of a wild-type and mutant
embryo at an early stage of development, where the reduced
expression in FoxF1−/− is very apparent. (C,C) In situ hybrid-
ization of whole embryos at E13.5. The strong expression of
Tcf21 in the muscle of the herniated gut (C) is strongly reduced
in Foxf2 mutant embryos (C). The insets show a dissected pos-
terior region of the small intestine, the caecum, and the proxi-
mal colon of wild type (C) and Foxf2−/− (C), clearly displaying
reduced Tcf21 expression in Foxf2 mutants. (D) Many of the
regulatory connections between Binou and its target genes are
conserved in mice, suggesting an ancient wiring of the VM regu-
latory network.
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(1) Biniou binds to enhancers in a temporally regulated
manner. As Biniou is expressed from VM specification
until the end of development, this demonstrates that ad-
ditional regulatory inputs are necessary to restrict Biniou
activity. For the early-bound enhancers, some temporal
specificity likely stems from combinatorial binding
with Bagpipe. However, other TFs are also likely to be
involved.
(2) Biniou-bound CRMs drive expression in diverse
subtypes of VM. This restricted spatial expression again
necessitates combinatorial regulation with additional fac-
tors. We propose that much of this spatial specificity is
conferred through Biniou-mediated feed-forward regula-
tion: Biniou regulates a large group of spatially restricted
TFs and components of cell signaling pathways (Supple-
mentary Fig. 7) that likely target different subsets of these
CRMs. Such feed-forward regulation is a prevalent feature
in many developmental networks (Davidson et al. 2002;
Schroeder et al. 2004; Inoue et al. 2005; Koide et al. 2005;
Sandmann et al. 2007a).
(3) The timing of Biniou enhancer occupancy is tightly
correlated with the time span of enhancer activity. This
is surprising given the extensive combinatorial binding
necessary to produce restricted spatio–temporal expres-
sion of Biniou CRMs and suggests Biniou recruitment is
the key trigger for enhancer activity. Taken together, our
data indicate that Biniou provides VM enhancers with
the competence to be expressed within the VM at the
appropriate stage, and that these modules integrate ex-
tensive inputs from additional factors to restrict Biniou
activity.
(4) Although bagpipe and biniou mutants phenocopy
each other, their regulatory role within the underlying
network is very different. The majority of Bagpipe’s
regulation occurs via combinatorial binding to Biniou–
Bagpipe CRMs to regulate a shared set of target genes.
From a limited number of enhancers assayed in vitro,
Bagpipe’s contribution to enhancer activity is mainly co-
operative, with little regulatory potential by itself (Fig.
5G). In contrast, Biniou targets an additional large group
of CRMs during VM specification, and can regulate their
activity independently of Bagpipe. This underlying na-
ture of Biniou and Bagpipe’s regulatory potential was not
apparent from genetic studies due to the severity of their
mutant phenotypes.
(5) Biniou provides regulatory input at all stages of VM
development, not just specification. Moreover, the tem-
poral regulation of target genes at either early or late
stages reflects developmental progression. For example,
17% of target genes regulated late in development are
involved in the formation or function of the neuromus-
cular junction, compared with 4% of continuously regu-
lated targets and 0% of early targets (Supplementary
Table 5). This reflects the requirement of neuronal
stimulation for gut muscle contraction at the end of em-
bryogenesis. Our results also revealed a new role for
Biniou as a direct regulator of the transcriptional pro-
gram within the foregut and hindgut VM.
(6) The underlying cis-regulatory circuitry between
Biniou and its target genes is at least partially conserved
from flies to mice. Four genes that are directly regulated
by Biniou in flies require FoxF function for their expres-
sion in mice. Due to the limited number of characterized
FoxF direct target genes in vertebrates, it is currently too
early to determine if VM development represents an an-
cient trans-bilaterian kernel (Davidson 2006).
Taken together, our data indicate that Biniou serves as
a universal regulator of VM: The broad expression of
Biniou in all VM subtypes and its extensive occupancy
on VM enhancers strongly suggests that Biniou provides
all VM cells, regardless of their origin or ultimate cell
fate, with their VM identity.
Materials and methods
Expression profiling of biniou mutant embryos
A biniou loss-of-function allele (bin1l ) (Zaffran et al. 2001) was
outcrossed to remove spurious mutations potentially main-
tained by the balancer chromosome. Pure populations of homo-
zygous mutant embryos were obtained as described previously
(Furlong et al. 2001a,b). Embryos ectopically expressing Biniou
were collected from transheterozygote parents with twist-24B-
Gal4 and UAS-biniou. One-hour collections of mutant and
wild-type (Canton S) embryos were obtained and processed in
parallel. The embryo staging was verified to ensure that mutant
and wild-type embryos were tightly stage-matched. For each
developmental time point, four independent embryo collections
and hybridizations were performed. RNA amplification, label-
ing, and hybridization was conducted as described previously
(Sandmann et al. 2006). The microarrays used for this study
contain one 60-mer oligonucleotide for every predicted Dro-
sophila gene (INDAC design; for details see FlyMine).
ChIPs
ChIPs were performed as described previously (Sandmann et al.
2007b). ChIPs were conducted with two independent antibodies
for each TF. For Biniou, both antisera were generated in this
study, raised against amino acids 135–614. For Bagpipe, we used
one antibody generated in this study (raised against amino acids
1–382), and a second antibody generously donated by M. Frasch
(University of Erlangen-Nuremberg, Erlangen, Germany). For
each developmental time period, four independent embryo col-
lections, chromatin preparations, and immunoprecipitations
were obtained. Both immunoprecipitations and mock reactions
were hybridized against a genomic reference sample, using ap-
propriate dye swap controls to minimize dye biases.
Analysis of array data and accession numbers
The raw data from both tiling and cDNA arrays were normal-
ized using print-tip combined with LOWESS normalization. To
identify differentially expressed genes in biniou mutant em-
bryos, the biniou mutant samples were hybridized directly
against the stage-matched wild-type samples. A one-class SAM
analysis was performed on four independent biological repeats
per time point, using Mev (Saeed et al. 2003). Genes with a
q < 0.01 and a fold change of log2 > 0.7 or less than −0.7 at one
or more developmental time points were considered differen-
tially expressed.
To identify ChIP-enriched fragments, the experimental samples
were hybridized against genomic DNA. The four mock/genomic
DNA and four ChIP/genomic DNA ratios were compared in
a two-class paired SAM analysis. Only genomic regions with
a q < 0.01 and a fold enrichment >0.7 (log2) were considered
Jakobsen et al.
2458 GENES & DEVELOPMENT
to be significantly bound. All microarray data are available
from ArrayExpress (accession nos. E-TABM-249, E-TABM-247,
E-TABM-250, E-TABM-251, and A-MEXP-718), or alternatively
at http://furlonglab.embl.de/data.
Biniou and Bagpipe binding and mutant expression data can
be visualized using a searchable Web site at http://furlonglab.
embl.de/data/browse_chip_mod.
Generation of transgenic reporter strains
Genomic fragments of the following coordinates were cloned
into the pH-Stinger vector (Barolo et al. 2000) for germline trans-
formation: chr3R: 2302000–2302930 (CG2330-VME); chr3R:
18854362–18855948 (lmd-VME); chr3R: 17218144–17220402
(bap-FH-VME); chr2L: 16482002–16483204 (dac-VME); chr3R:
27528340–27531000 (ttk-VME); chr3L: 4000681–4002080 ( fd64a-
eVME); chr2R: 13274315–13275818 (HLH54F-VME); chr2R:
7524515–7526750 (otk-VME); chr2L: 19031758–19033780
(mib2-VME); chr3L: 3997574–3999422 (fd64a−l−VME); chr2R:
19379642–19381101 (ken-VME); chr2R: 9758088–9758850
(CG8503-VME); chr2L: 3813750–3815714 (based on Genome re-
lease 4.2). For all enhancers, with the exception of ken, at least
two independent transgenic lines were obtained and assayed.
In situ hybridization
In situ hybridizations in Drosophila embryos were done using
standard protocols and as described previously (Furlong et al.
2001a). The following ESTs were used to generate digoxigenin-
labeled probes: GH28686 (mib2), RH55216 (CG17181), LD47926
(lmd), LD17463 (salm), LP21473 (otk), GM09101 (ttk), GH12495
(ken), RE64054 (dac), and LD42676 (CG2330). The probe di-
rected against the GFP transcript was made by amplifying
the GFP sequence from the pH-Stinger vector. bin cDNA (gift
from M. Frasch) was used to generate a Biotin-labeled bin
probe. Double in situs were performed by using -DIG-POD and
-Biotin-POD (Roche) antibodies and were detected sequen-
tially with Cy3 and Cy5 (PerkinElmer TSA kit).
Mouse embryos were collected from C57Bl/6 pregnant fe-
males at E8.5 (Foxf1 mutant) or E13.5 (Foxf2 mutant). Homo-
zygous mutants and wild-type littermates were identified by
PCR genotyping, as described previously (Mahlapuu et al.
2001b; Wang et al. 2003). Embryos were fixed in 4% para-
formaldehyde overnight and dehydrated in methanol. Whole-
mount in situ hybridization with digoxigenin-labeled ribo-
probes was performed with an InsituPro robot (Intavis AG), us-
ing a standard protocol (Rosen and Beddington 1994) with minor
adjustments to fit the robotic format.
Luciferase assays
Drosophila Kc-cells were transiently transfected using standard
protocols (Cellfectin, Invitrogen). TFs Biniou (cDNA from
M. Frasch), Bagpipe (EST, RE13967), or Mef2 (EST GH 24,154),
were expressed using the pAC5.1b vector (Invitrogen). Enhancer
activity was assayed using the pGL3 luciferase reportor vector
(Promega) modified with a hsp70 promotor (see transgenic re-
porter strains for enhancer coordinates). The total amount of DNA
transfected was normalized by substituting with empty pAC5.1b
vector. Luciferase assay was performed as described (Dual-
luciferase Reporter assay, Promega), employing a PerkinElmer
1420 Luminescence Counter. Categories were compared with a
t-test.
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